Comprehensive Genomic Profiling of High-Risk Pediatric Cancer Patients Has a Measurable Impact on Clinical Care.
Ryan J SummersSharon M CastellinoChristopher C PorterTobey J MacDonaldGargi D BasuSzabolcs SzelingerManoj K BhasinThomas CashAlexis B CarterRobert Craig CastellinoJason R FangusaroSarah G MitchellMelinda G PaulyBojana PenchevaDaniel S WechslerDouglas K GrahamKelly C GoldsmithPublished in: JCO precision oncology (2022)
Paired tumor/normal whole-exome sequencing and tumor RNA Seq of de novo or relapsed/refractory tumors was feasible and clinically impactful in high-risk pediatric cancer patients.